Ionis says FDA approves ZANVASTRO for Alexander disease
Ionis said the FDA approved ZANVASTRO (zilganersen) as the first disease-modifying treatment for Alexander disease.
Ionis announced FDA approval of ZANVASTRO (zilganersen) as the first disease—modifying treatment for Alexander disease.Key Highlights:Original SEC Filing: IONIS PHARMACEUTICALS INC [ IONS ] - 8-K - Sep. 04, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important…